The National Agency for Food and Drug Administration and Control (NAFDAC) has approved the production of Chloroquine for clinical trials in the search for a cure for COVID-19.
Director-General of the agency, Mojisola Adeyeye, made the announcement on Friday at the NAFDAC headquarters in Lagos.
She, however, pointed out that NAFDAC is not approving Chloroquine for the treatment of COVID-19 but for clinical trials to find treatment for the virus.
“In the case of Chloroquine, it has been demonstrated in the literature and with clinical research which is still ongoing, that Chloroquine is superior to the Placebo.
“NAFDAC is not approving Chloroquine as a product that has can be used for Coronavirus because there is no submission to us for registration but because it is under clinical trials, NAFDAC approves medicines meant for clinical trials.
“Therefore the medicine is being approved just for the clinical trials,” Adeyeye said.
She, therefore, called on experts and researchers that are interested in doing a clinical trial on Chloroquine to approach approved outlets.
“Right now, we have asked one company to make a batch of Chloroquine for the purpose of clinical trial,” Adeyeye added.
The NAFDAC DG also urged Nigerians not to use Chloroquine as anti-malaria.
“Chloroquine is banned for use as anti-malaria
Source: Channels TV
(48)
Donate to osun.life Good journalism costs a lot of money. Yet only good journalism can ensure the possibility of a good society, an accountable democracy, and a transparent government. For continued free access to the best investigative journalism in Osun State, we ask you to consider making a modest support to our efforts towards a just and equitable society in Osun State. DONATE NOW
Are you an indigene or resident of Osun? Click to join our WhatsApp group and receive instant news alerts JOIN NOW
To share a story on osun.life: CLICK